|
⚲
|
| Keyboard |
| Shreedhar Vijay
✚
|
|
|---|---|
| CIK # | 0001778051 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001778051] | |
| 4 | [0001778051] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Shreedhar Vijay | |
| Adamas Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Adamas Pharmaceuticals Inc ADMS
Stock Option (Right to Buy) · derivative
|
2021-11-24 | Disposed to issuer | 47,500 | ||
|
Adamas Pharmaceuticals Inc ADMS
Stock Option (Right to Buy) · derivative
|
2021-11-24 | Disposed to issuer | 137,500 | ||
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2021-11-24 | Tender | 186,786 | ||
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2021-11-24 | Grant | 18,750 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2021-06-21 | Sell | 6,200 | $5.16 | 31,992 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2021-03-22 | Sell | 1,051 | $5.50 | 5,780 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2021-03-02 | Grant | 75,000 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2021-02-01 | Sell | 4,514 | $6.39 | 28,844 |
|
Adamas Pharmaceuticals Inc ADMS
Stock Option (Right to Buy) · derivative
|
2020-03-17 | Grant | 47,500 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2020-03-17 | Grant | 23,750 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2019-06-07 | Grant | 68,750 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Stock Option (Right to Buy) · derivative
|
2019-06-07 | Grant | 137,500 | $0.00 |